We observed higher levels of CDKN2A protein in the tumor samples of patients with lower nodal status, N0 vs. N2+N3 (3.8763 (2.8281–8.1203) vs. 2.3377 (1.3179–3.7278); p = 0.0362). This evidence concerns the gene CDKN2A and neoplasm.